NASDAQ:NBRV Shareholder Notice: Lawsuit Alleges Misleading Statements by Nabriva Therapeutics Plc
An investor, who purchased shares of Nabriva Therapeutics plc (NASDAQ: NBRV), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by Nabriva Therapeutics plc.
View full press release